Corgenix Corgenix

State-of-the-Art Solutions for the Medical Diagnostic Industry State-of-the-Art Solutions for the Medical Diagnostic Industry

Main menu

Skip to primary content
Skip to secondary content
  • About Us
    • Our Vision
    • Our Management Team
    • Our Board
    • What Sets Us Apart
    • Our Facilities
  • Investor Relations
    • Overview
    • Corporate Governance
    • Investor Materials
    • SEC Filings
    • News Releases
    • Investor Inquiries
    • Upcoming Events
  • Strategic Partners
    • Overview
    • Our Partners
    • Featured Partnership
  • Products
    • Autoimmune Disease Diagnostic Products
    • Vascular Disease Products
    • Infectious Disease Products
    • Non-Invasive Liver Biomarkers
    • Instrumentation
  • Contact
    • General Information
    • Sales & Customer Service
    • Contract Services
    • Investor Inquiries
    • Careers

Recent News

  • May 22, 2013
    Corgenix Announces Diagnostic Development Agreement with Lilly »
  • May 14, 2013
    Corgenix Reports Third Quarter Fiscal 2013 Financial Rresults »
  • May 7, 2013
    Corgenix Gains CE Mark for ReLASV® Antigen Rapid Test for Diagnosis of Lassa Fever »
  • May 3, 2013
    Corgenix to Host Conference Call To Discuss Third Quarter Results »

Featured Product

AspirinWorks Test Kit

AspirinWorks Test Kit

The only FDA-cleared test allowing doctors to determine aspirin effect in apparently healthy individuals post aspirin ingestion. The test measures the level of thromboxane metabolite in urine.

more >>

Featured Partners

usamriid DiaDexus230x93 scripps_research_institute Dynex Logo lg randox elitechgroup zalgen_labs nanomix axa_diagnostics autoimmune_technologies vybion tulane_university consortium bgmedicine

Stock Performance

CONX

NASDAQ:

VOLUME:

$

PRICE:

Home | Site Map | Privacy Policy | Terms of Use

Copyright © 2013. Corgenix. All rights reserved.